River Street Advisors LLC Makes New $288,000 Investment in Cardinal Health, Inc. $CAH

Key Points

• River Street Advisors LLC has invested $288,000 in Cardinal Health, acquiring 1,713 shares during the 2nd quarter.
• Several institutional investors significantly increased their holdings in Cardinal Health, with Wellington Management boosting its position by 1,666.7% in the 1st quarter.
• Cardinal Health recently announced a quarterly dividend of $0.5107, representing a 1.3% dividend yield with a payout ratio of 31.63%.

River Street Advisors LLC acquired a new position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) in the 2nd quarter, according to its most recent disclosure with the SEC. The fund acquired 1,713 shares of the company's stock, valued at approximately $288,000.

Several other institutional investors have also modified their holdings of CAH. Wellington Management Group LLP lifted its position in shares of Cardinal Health by 1,666.7% during the 1st quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company's stock worth $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Cardinal Health by 40.0% during the 1st quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company's stock worth $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI lifted its position in shares of Cardinal Health by 4,935.9% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company's stock worth $130,434,000 after purchasing an additional 927,950 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Cardinal Health during the 1st quarter worth $106,065,000. Finally, T. Rowe Price Investment Management Inc. purchased a new stake in shares of Cardinal Health during the 1st quarter worth $104,951,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several equities research analysts have recently issued reports on the stock. Leerink Partners decreased their price objective on shares of Cardinal Health from $188.00 to $186.00 and set an "outperform" rating for the company in a research report on Tuesday, August 12th. UBS Group reaffirmed a "buy" rating on shares of Cardinal Health in a research report on Tuesday, August 12th. Wells Fargo & Company reissued an "overweight" rating and issued a $185.00 price target (up from $183.00) on shares of Cardinal Health in a research report on Wednesday, August 13th. Argus set a $189.00 price target on shares of Cardinal Health in a research report on Friday, August 22nd. Finally, Jefferies Financial Group set a $150.00 price target on shares of Cardinal Health in a research report on Tuesday, August 12th. Eleven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $165.93.

Insiders Place Their Bets

In related news, insider Michelle D. Greene sold 13,500 shares of the stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total transaction of $2,009,070.00. Following the completion of the transaction, the insider directly owned 14,976 shares of the company's stock, valued at $2,228,728.32. This represents a 47.41% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, insider Jessica L. Mayer sold 38,078 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total transaction of $5,666,767.96. Following the transaction, the insider directly owned 48,457 shares of the company's stock, valued at $7,211,370.74. This represents a 44.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 271,676 shares of company stock valued at $40,489,525. 0.12% of the stock is owned by insiders.

Cardinal Health Stock Performance

Shares of NYSE:CAH opened at $158.50 on Friday. The company has a 50-day simple moving average of $152.12 and a 200-day simple moving average of $150.09. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44. The stock has a market capitalization of $37.66 billion, a price-to-earnings ratio of 24.57, a PEG ratio of 1.34 and a beta of 0.71.

Cardinal Health (NYSE:CAH - Get Free Report) last announced its earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, beating analysts' consensus estimates of $2.03 by $0.05. Cardinal Health had a net margin of 0.70% and a negative return on equity of 74.45%. The business had revenue of $60.16 billion during the quarter, compared to analysts' expectations of $60.91 billion. During the same period in the prior year, the company earned $1.84 earnings per share. The business's revenue was up .5% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. As a group, research analysts forecast that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be issued a $0.5107 dividend. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.3%. The ex-dividend date of this dividend is Wednesday, October 1st. Cardinal Health's dividend payout ratio is presently 31.63%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.